Publication:
Discovery of Novel Cathepsin D Inhibitors by High-Throughput Virtual Screening

Simple item page
dc.contributor.authorDebnath, Abhijit
dc.contributor.authorChaudhary, Hema
dc.contributor.authorKumar, Rajesh
dc.contributor.authorShokeen, Ankit
dc.contributor.authorKhurana, Riya
dc.date.accessioned2025-02-28T06:22:42Z
dc.date.available2025-02-28T06:22:42Z
dc.date.issued2023
dc.description.abstractCathepsin D (CatD) is a cancer-associated inflammation protein that plays an important role in cancer-associated inflammation, osteoarthritis, and various neurodegenerative diseases. CatD is genetically stable and does not easily develop drug resistance. Targeting CatD is an interesting strategy for both cancer therapy and cancer prevention. Thus, we have tried working on CatD as a therapeutic target in this research. To identify potent CatD inhibitors, we have screened the Million Molecules Database, Natural Product Database, and NCI Database. Top hits have been filtered based on various drug-likeness rules, followed by ADME profiling, toxicity prediction, and Consensus Molecular docking. Our research work resulted in three molecules: ZINC12198861 (-9.6 Kcal/mol), ZINC2438311 (-9.5 kcal/Mol), and ZINC14533276 (-8.9 kcal/mol) are stability-binding at the active site of CatD with strong binding affinity, drug-like properties, effective ADME properties, low toxicity, and high stability. Inhibiting CatD with these identified molecules will promote apoptosis and cure cancer-associated inflammation and osteoarthritis. © 2023 by the authors.
dc.identifier.doihttps://doi.org/10.33263/BRIAC135.483
dc.identifier.issn20695837
dc.identifier.urihttps://dl.bhu.ac.in/ir/handle/123456789/59354
dc.publisherAMG Transcend Association
dc.subjectAlzheimer's disease
dc.subjectcancer
dc.subjectcancer-associated inflammation
dc.subjectCatD
dc.subjectCatD inhibitors
dc.subjectCathepsin D
dc.subjectCathepsin D inhibitors
dc.subjectinflammation
dc.subjectmolecular docking
dc.subjectosteoarthritis
dc.titleDiscovery of Novel Cathepsin D Inhibitors by High-Throughput Virtual Screening
dc.typeArticle
dspace.entity.typePublication
journal.titleBiointerface Research in Applied Chemistry
journalvolume.identifier.volume13

Files

Collections

2023